A phase 1 study of MM-121 (a fully human monoclonal antibody targeting the epidermal growth factor receptor family member ErbB3) in combination with cetuximab and irinotecan in patients with advanced cancers.
James M. Cleary
No relevant relationships to disclose
Autumn Jackson McRee
No relevant relationships to disclose
Bert H. O'Neil
No relevant relationships to disclose
Sunil Sharma
Stock Ownership - Beta Cat Pharmaceuticals; ConverGene; Salarius Pharmaceuticals
Joseph Pearlberg
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Sara Manoli
Employment or Leadership Position - Merrimack Pharmaceuticals
Stock Ownership - Merrimack Pharmaceuticals
William Lloyd Kubasek
Employment or Leadership Position - Merrimack Pharmaceuticals
Stock Ownership - Merrimack Pharmaceuticals
W. Michael Korn
No relevant relationships to disclose